Secondary Amenorrhea
Absence of menses for ≥3 months (regular cycles) or ≥6 months (irregular cycles) in a previously menstruating woman.
Also known as: secondary amenorrhea, missed menses, absent menses
Overview
Cessation of menstruation for at least 3 consecutive months in a woman with previously regular cycles, or 6 months in a woman with previously irregular cycles.
Epidemiology
Affects ~3-4% of reproductive-age women. Pregnancy is by far the most common cause; pathologic causes include PCOS (most common pathologic), hypothalamic amenorrhea, hyperprolactinemia, thyroid disease, and primary ovarian insufficiency.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Secondary Amenorrhea outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Recent pregnancy or breastfeeding
- Significant weight loss, low BMI, eating disorder
- Excessive exercise (endurance athletes, dancers)
- Major psychological stress
- Antipsychotics, opioids, hormonal contraceptives
- Intrauterine instrumentation (Asherman syndrome)
- Family history of premature ovarian insufficiency
Pathophysiology
Menstruation requires cyclic ovarian estrogen/progesterone production with intact endometrial responsiveness and patent outflow. Common pathways: hypothalamic suppression (energy deficit, stress), pituitary lesions (prolactinoma), ovarian failure (POI, chemo/radiation), endometrial damage (Asherman from D&C, infection), and androgen excess (PCOS) producing anovulation.
Clinical presentation
Symptoms
- Cessation of menses
- Symptoms of underlying cause: galactorrhea (prolactinoma), hot flashes (POI/menopause), hirsutism (PCOS), heat/cold intolerance (thyroid), weight changes
- Cyclic pelvic pain may suggest outflow obstruction (cervical stenosis post-procedure)
Signs / physical exam
- BMI, vital signs
- Visual field testing if pituitary lesion suspected
- Thyroid exam, breast exam (galactorrhea)
- Pelvic exam: vaginal atrophy (low estrogen), uterine size, adnexal masses
- Skin: acanthosis nigricans, hirsutism, acne, striae
Differential diagnosis
- Pregnancy — Most common cause; always check hCG
- PCOS — Hyperandrogenism + chronic anovulation
- Functional hypothalamic amenorrhea — Low weight, exercise, stress; low FSH/LH/estradiol
- Hyperprolactinemia — Galactorrhea; check medications, pregnancy, TSH; pituitary MRI
- Thyroid disease — Hypo- or hyperthyroid symptoms; abnormal TSH
- Primary ovarian insufficiency — Hot flashes, vaginal dryness <40 yo; elevated FSH on two occasions
- Asherman syndrome — Amenorrhea or hypomenorrhea after D&C, endometritis, or uterine surgery; absent withdrawal bleed; hysteroscopy diagnostic
- Cushing syndrome / hyperandrogenism (CAH, tumor) — Virilization, central obesity, striae; specific endocrine testing
Diagnostic workup
Diagnostic criteria
Progesterone challenge test (medroxyprogesterone 10 mg × 10 days) can assess estrogen status: bleeding suggests adequate estrogen + patent outflow (anovulation pattern); no bleeding suggests low estrogen OR outflow obstruction OR endometrial unresponsiveness — confirm with estrogen-progestin challenge.
Labs
- Pregnancy test (urine or serum hCG) — always first
- TSH and prolactin
- FSH (high → POI; low/normal → central or PCOS)
- If hyperandrogenism: total testosterone, DHEAS, 17-OHP
- Estradiol if FSH abnormal
Imaging
- Pelvic ultrasound if structural cause suspected
- Brain MRI (pituitary protocol) for elevated prolactin or hypogonadotropic hypogonadism
- Hysteroscopy or saline sonohysterography if Asherman suspected (history of D&C, endometritis)
Diagnostic algorithm
flowchart TD
A[Secondary amenorrhea] --> B[hCG]
B -->|Positive| C[Pregnancy]
B -->|Negative| D[TSH, prolactin]
D -->|High prolactin| E[Pituitary MRI<br/>Dopamine agonist]
D -->|Abnormal TSH| F[Thyroid treatment]
D -->|Normal| G[FSH, estradiol]
G -->|High FSH| H[Primary ovarian<br/>insufficiency<br/>repeat in 1 month]
G -->|Low/normal FSH| I{Hyperandrogenism?}
I -->|Yes| J[PCOS workup]
I -->|No| K[Progesterone challenge]
K -->|Withdrawal bleed| L[Anovulation:<br/>functional HA, PCOS]
K -->|No bleed| M[E+P challenge:<br/>bleed = outflow OK<br/>no bleed = Asherman]Treatment
First-line
- Treat the underlying cause
- Pregnancy: prenatal care
- PCOS: see PCOS entry — COCP or cyclic progestin
- Functional hypothalamic amenorrhea: nutritional restoration, reduce exercise, address stress; CBT for those with eating disorder
- Hyperprolactinemia: dopamine agonists (cabergoline preferred, bromocriptine alternative)
- Thyroid disease: levothyroxine or antithyroid therapy
- POI: hormone therapy (estrogen + progestin) until average age of menopause
Asherman syndrome
- Hysteroscopic lysis of adhesions
- Postoperative estrogen to promote endometrial regrowth
- Intrauterine device or balloon to prevent re-adhesion
Premature ovarian insufficiency
- Hormone replacement until ~age 51 (mean menopause age)
- Calcium and vitamin D
- Fertility counseling — pregnancy possible with donor oocytes
- Screen for autoimmune comorbidities (adrenal, thyroid)
Complications
- Infertility
- Osteoporosis from prolonged hypoestrogenism
- Endometrial hyperplasia from unopposed estrogen (PCOS, obesity)
- Cardiovascular risk in untreated POI
- Psychological distress
PANCE pearls
- Always rule out pregnancy first — even with denied sexual activity, contraception use, or recent menses.
- Functional hypothalamic amenorrhea is a diagnosis of exclusion; first restore energy availability before starting hormone therapy.
- Hyperprolactinemia from medications (antipsychotics, metoclopramide, opioids) usually causes prolactin <100 ng/mL; tumors cause higher levels.
- POI is diagnosed with two FSH levels >25-40 IU/L drawn at least 1 month apart in a woman under 40.
- A withdrawal bleed after progesterone challenge implies adequate endogenous estrogen — proceed with workup for anovulation, not POI.
References
- ACOG CO 605 — ACOG Committee Opinion 605: Primary Ovarian Insufficiency in Adolescents and Young Women
- Endocrine Society 2017 — Functional Hypothalamic Amenorrhea: Endocrine Society Clinical Practice Guideline (Gordon et al., JCEM 2017)
- Endocrine Society 2011 — Diagnosis and Treatment of Hyperprolactinemia: Endocrine Society Clinical Practice Guideline (Melmed et al., JCEM 2011)
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.